Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofloxacin vs Levofloxacin for Sepsis Prevention in PCNL
NCT04374188Unknown
- Start
- Sep 2019
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of ciprofloxacin in sepsis (2 arms). Primary endpoint: Effect of ciprofloxacin versus levofloxacin duration before PCNL at 12 months. Status: unknown.
02
Drugs
ciprofloxacin
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT04374188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04374188.